Dr. Gerber is a leukemia researcher and clinician joining NYU Langone from Worcester, Mass.-based UMass Memorial Health where he previously served as the director of the cancer center and chief of hematology and oncology, according to a July 24 news release from NYU Langone.
His research has been focused on “improving the identification and targeting of the stem cells at the root of leukemia and other hematologic diseases, with the goal of personalizing therapy and developing treatments that are more effective and less toxic,” the release said.
Dr. Gerber is a member of the American Society of Hematology and the American Society of Clinical Oncology. He also is associate editor of hematology content for HemOnc Today.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
